Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Entresto Patent Expiry to Weigh on Novartis as Profit Seen Falling in 2026

Novartis Cosentyx gets USFDA approval

Ruchika Sharma26 Dec 2021 9:45 AM IST

Basel: Novartis has announced the US Food and Drug Administration (USFDA) has approved Cosentyx (secukinumab) for the treatment of active...

Biogen gets USFDA Fast Track designation for lecanemab

Ruchika Sharma26 Dec 2021 9:30 AM IST

Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that lecanemab, an investigational anti-amyloid beta (Aβ) protofibril antibody for the...

CanSino Biologics COVID vaccine shows 57.5 percent efficacy in Phase 3 study

Ruchika Sharma26 Dec 2021 9:15 AM IST

Beijing: CanSino Biologics Inc's vaccine was 57.5% effective against symptomatic COVID-19 and 91.7% against severe disease four weeks or longer after...

Misquoted: Experts clarify on Lancet study claiming protection offered by Covishield declines after 3 months

Ruchika Sharma25 Dec 2021 3:40 PM IST

New Delhi: The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca Covid-19 vaccine Covishield declines after...

Merck, Ridgeback Molnupiravir gets special approval for emergency in Japan

Ruchika Sharma25 Dec 2021 2:46 PM IST

Kenilworth: Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics have announced that Japan's Ministry of Health,...

DCGI seeks Serum Institute to submit more data for Covovax emergency authorization

Ruchika Sharma25 Dec 2021 2:18 PM IST

New Delhi: The Drugs Controller General of India (DCGI) has raised queries and sought more data from Serum Institute of India over its application...

Lupin bags USFDA nod for generic equivalent of Edarbi Tablets

Ruchika Sharma25 Dec 2021 2:16 PM IST

Mumbai: Global pharma major Lupin Limited has announced that the company has received tentative approval from the United States Food and Drug...

Roche at-home COVID rapid test gets USFDA approval

Ruchika Sharma25 Dec 2021 1:01 PM IST

Basel: Roche has recently announced that the U.S. Food and Drug Administration (USFDA) has granted Emergency Use Authorization (EUA) for its...

Sucharita Rao Palepu appointed as Granules India independent director

Ruchika Sharma24 Dec 2021 1:22 PM IST

New Delhi: Drug maker, Granules india has recently announced the appointment of Mrs. Sucharita Rao Palepu as an Additional Director, categorized as...

Biocon arm gets DCGI nod to initiate clinical study for Itolizumab

Ruchika Sharma24 Dec 2021 1:13 PM IST

Itolizumab is a clinical-stage, first-in-class anti-CD6 monoclonal antibody that selectively targets the CD6-ALCAM pathway.

Finally Molnupiravir gets USFDA nod

Ruchika Sharma24 Dec 2021 11:36 AM IST

Kenilworth: A day after Pfizer's Paxlovid bagged the U.S. Food and Drug Administration (USFDA) Emergency Use Authorization (EUA) nod, Merck's...

Pharma will give momentum in 2022, says OPPI

Ruchika Sharma24 Dec 2021 11:15 AM IST

New Delhi: Having contributed to the world during the challenging pandemic times by supplying 60 per cent of the global COVID-19 vaccine requirements,...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok